Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -62.07%93.77M | ---- | -38.74%247.22M | ---- | -60.16%403.56M | ---- | 11.02%1.01B | ---- | 6.31%912.34M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 67.80%-19.71M | ---- | -144.09%-61.23M | ---- | 24.08%-25.09M | ---- | -505.40%-33.04M | ---- | -296.37%-5.46M |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | 76.01%477K | ---- | -46.76%271K | ---- | -49.00%509K | ---- | 12,575.00%998K |
| Asset sale loss (gain): | ---- | ---- | ---- | ---2.26M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---2.25M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---10K | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | -43.39%8.01M | ---- | -24.85%14.15M | ---- | 3.58%18.83M | ---- | 40.73%18.18M | ---- | 56.14%12.92M |
| -Depreciation | ---- | -43.39%8.01M | ---- | -24.85%14.15M | ---- | 3.58%18.83M | ---- | 40.73%18.18M | ---- | 56.14%12.92M |
| Financial expense | ---- | -14.12%298K | ---- | 64.45%347K | ---- | -48.91%211K | ---- | 6.17%413K | ---- | --389K |
| Special items | ---- | -7.89%6.76M | ---- | 625.40%7.34M | ---- | -70.38%1.01M | ---- | 191.80%3.42M | ---- | -57.00%1.17M |
| Operating profit before the change of operating capital | ---- | -56.75%89.12M | ---- | -48.33%206.05M | ---- | -60.21%398.8M | ---- | 8.67%1B | ---- | 6.25%922.35M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | 60.67%-54.3M | ---- | -888.29%-138.07M | ---- | 122.89%17.52M | ---- | 28.79%-76.53M | ---- | -650.37%-107.46M |
| Accounts payable increase (decrease) | ---- | -19.59%47.67M | ---- | 1,400.57%59.28M | ---- | -167.91%-4.56M | ---- | 246.49%6.71M | ---- | -106.25%-4.58M |
| Special items for working capital changes | ---- | -119.09%-60.64M | ---- | 240.67%317.65M | ---- | -56.76%-225.81M | ---- | -873.97%-144.05M | ---- | 149.19%18.61M |
| Adjustment items for working capital changes | ---- | ---1.45M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from business operations | 2,408.44%46.93M | -95.41%20.4M | -99.12%1.87M | 139.27%444.91M | 61.05%212.33M | -76.42%185.95M | -63.01%131.84M | -4.88%788.49M | 47.97%356.41M | -6.78%828.92M |
| China income tax paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -23.71%-265M | ---- | 1.52%-214.21M |
| Other taxs | 28.33%-7.39M | 74.14%-18.8M | 76.74%-10.31M | -41.30%-72.7M | 35.89%-44.33M | ---51.45M | 48.86%-69.15M | ---- | -46.23%-135.23M | ---- |
| Net cash from operations | 568.52%39.54M | -99.57%1.6M | -105.02%-8.44M | 176.74%372.21M | 167.99%167.99M | -74.31%134.5M | -71.66%62.69M | -14.84%523.49M | 49.06%221.19M | -8.49%614.72M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -32.73%8.46M | -67.80%19.71M | -56.30%12.58M | 242.75%61.23M | 65.83%28.78M | -45.94%17.86M | 161.16%17.35M | 505.40%33.04M | --6.65M | 296.37%5.46M |
| Loan receivable (increase) decrease | -90.92%42M | 321.77%705.95M | 292.69%462.45M | -199.77%-318.33M | -187.04%-240M | -120.20%-106.19M | -67.30%275.75M | 240.03%525.67M | 743.22%843.22M | -1,565.48%-375.4M |
| Sale of fixed assets | --214K | ---- | ---- | --556K | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | ---- | 17.65%-42K | -64.35%-1.11M | 95.00%-51K | ---676K | 89.86%-1.02M | ---- | -213.53%-10.06M | ---- | 80.16%-3.21M |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | -160.25%-7.56M | ---- | -406.63%-2.9M | ---- | 65.65%-573K |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---8.08M | ---- | ---- |
| Other items in the investment business | ---- | ---- | ---- | ---- | -1,281.39%-110M | ---- | -270.72%-7.96M | ---- | -3,456.25%-2.15M | ---- |
| Net cash from investment operations | -89.31%50.67M | 382.79%725.63M | 247.23%473.92M | -164.80%-256.59M | -212.89%-321.9M | -118.02%-96.9M | -66.36%285.14M | 243.87%537.68M | 747.17%847.72M | -769.16%-373.72M |
| Net cash before financing | -80.62%90.22M | 528.97%727.23M | 402.45%465.48M | 207.52%115.62M | -144.25%-153.91M | -96.46%37.6M | -67.46%347.82M | 340.33%1.06B | 330.23%1.07B | -61.67%240.99M |
| Cash flow from financing activities | ||||||||||
| Issuing shares | ---- | ---- | ---- | --247.33M | --247.33M | ---- | ---- | --781.52M | --765.68M | ---- |
| Interest paid - financing | 50.00%-79K | 14.12%-298K | ---158K | -64.45%-347K | ---- | 48.91%-211K | ---- | -6.17%-413K | ---- | -60.74%-389K |
| Dividends paid - financing | ---- | 12.41%-77.57M | ---77.57M | 79.88%-88.55M | ---- | -86.67%-440.2M | ---263.54M | -17.91%-235.81M | ---- | 37.50%-200M |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 104.75%3.74M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | 7.80%-6.41M | ---4.25M | ---6.95M | ---- | ---- |
| Other items of the financing business | ---- | ---- | ---- | ---- | 19.63%-2.57M | ---- | 41.14%-3.2M | ---- | 51.55%-5.44M | ---- |
| Net cash from financing operations | 98.40%-1.26M | -153.80%-82.43M | -132.35%-79.18M | 133.87%153.22M | 190.32%244.76M | -185.36%-452.39M | -135.65%-270.99M | 362.66%529.98M | 459.93%760.24M | 45.28%-201.78M |
| Effect of rate | ---- | 49.20%3.46M | ---- | -35.64%2.32M | 100.15%11K | 5,363.64%3.61M | -167.86%-7.35M | --66K | --10.82M | ---- |
| Net Cash | -76.97%88.95M | 139.84%644.8M | 325.19%386.3M | 164.81%268.85M | 18.25%90.85M | -126.07%-414.8M | -95.80%76.83M | 3,957.17%1.59B | 4,812.56%1.83B | -84.92%39.22M |
| Begining period cash | 35.31%2.48B | 17.33%1.84B | 17.33%1.84B | -20.81%1.56B | -20.81%1.56B | 413.73%1.98B | 413.73%1.98B | 11.35%384.6M | 11.35%384.6M | 304.50%345.38M |
| Cash at the end | 15.79%2.57B | 35.31%2.48B | 34.23%2.22B | 17.33%1.84B | -19.06%1.66B | -20.81%1.56B | -8.06%2.05B | 413.73%1.98B | 481.41%2.22B | 11.35%384.6M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Pak Chun Certified Public Accountants Limited | -- | Pak Chun Certified Public Accountants Limited | -- | PwC accounting firm | -- | KPMG | -- | PwC accounting firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.